Skip to main content
Premium Trial:

Request an Annual Quote

Be Noticed

With competition for positions as stiff as it is, early-career researchers need be on the lookout for any edge up they can muster. So, how about a sharp, succinct, standout CV?

"The distinctions between a lengthy, technical CV and a snappy résumé can make a big difference in a job search," Nature's Karen Kaplan says. Noting international stylistic inconsistencies — chiefly, that 'CV' and 'résumé' are generally synonymous in the UK and European Union, whereas in the US and Canada, CVs are comprehensive while résumés are concise — Kaplan says its important that early-career researchers understand their intended audience when documenting their credentials.

"Applicants can ensure that they are prepared for any eventuality by keeping multiple versions of résumés and CVs," she says. "In all countries, it is likely that the first viewer of an industrial application will not be a scientist, so an applicant's résumé (in the US) or CV (in the UK and EU) should be peppered liberally with words and phrases mined from the advert."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.